ArticleInternational neurourology journal2022

Efficacy and Safety of DA-8010, a Novel M3 Antagonist, in Patients With Overactive Bladder: A Randomized, Double-Blind Phase 2 Study.

Hee Seo Son et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.